---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-048585"
form_type: "8-K"
ticker: "DMAA"
cik: "0002028614"
company_name: "Drugs Made In America Acquisition Corp."
filed_at: "2026-04-28T23:59:59+00:00"
generated_at: "2026-05-15T03:15:53.283532+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# DMAA updates CFO equity to 175k shares, sets CEO compensation terms, both tied to definitive deal

## Summary
- CFO Saleem Elmasri's share grant increased from 100k to 175k ordinary shares, earned upon signing a definitive agreement and issued at closing of initial business combination.
- CEO Roger Bendelac receives 250k ordinary shares under same vesting trigger; monthly cash comp of $4,500 with up to $2,000 deferrable based on cash flow.
- Monthly CFO fee unchanged at $3,500; unpaid amounts accrue as binding obligations; shares replace prior unissued 100k.
- Compensation structures signal progress toward a business combination, though no definitive agreement announced as of April 28, 2026.

## SEC filing metadata
- accession: 0001213900-26-048585
- form_type: 8-K
- ticker: DMAA
- cik: 0002028614
- company_name: Drugs Made In America Acquisition Corp.
- filed_at: 2026-04-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2028614/000121390026048585/0001213900-26-048585-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2028614/000121390026048585/ea0287918-8k_drugs.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-048585
- JSON: https://secwatch.observer/filing/0001213900-26-048585.json
- Plain text: https://secwatch.observer/filing/0001213900-26-048585.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.